Differentiation Between Pleuropulmonary Desmoid Tumors and Solitary Fibrous Tumors: Role of Histology and Immunohistochemistry
Pleuropulmonary desmoid tumors (DTs) are extremely rare tumors that can histologically resemble other neoplasms more common to the lungs and pleura. Differentiating between desmoid tumors and solitary fibrous tumors (SFTs) can be particularly difficult. Other entities that may also be considered in the differential diagnosis include desmoplastic malignant mesothelioma, fibrosarcoma and variants, other spindle cell sarcomas, inflammatory myofibroblastic tumor, schwannoma, scar, and the capsule surrounding another process. Although the clinical and radiographic presentations of DTs and SFTs differ somewhat, and therefore clinical information can favor one diagnosis or the other, ultimately histological distinction is crucial.
Intrathoracic desmoid tumors typically arise in the chest wall and can protrude or extend into the pleural cavity secondarily. Rare cases, however, have been described that appear to represent true primary pleural or pulmonary neoplasms (Winer-Muram et al., 1994; Wilson et al., 1999; Iqbal et al., 2001; Andino et al., 2006). SFTs, on the other hand, have been reported in most organ systems, but most commonly arise in the pleura, forming well-circumscribed and sometimes polypoid or pedunculated pleural-based masses. Although defined histopathologic criteria exist to separate these tumors microscopically, these features may not be apparent in small or less representative samples. Fortunately, as reviewed by Andino et al. (2006) and Wilson et al. (1999), immunohistochemistry can aid in the distinction between primary pleuropulmonary DTs and SFTs, while also providing insight into the pathogenesis of these unusual neoplasms.
KeywordsAdenomatous Polyposis Coli Mantle Cell Lymphoma Desmoid Tumor Solitary Fibrous Tumor Inflammatory Myofibroblastic Tumor
Unable to display preview. Download preview PDF.
- Andino, L., Cagle, P.T., Murer, B., Lu, L., Popper, H.H., Galateau-Salle, F., Sienko, A.E., Barrios, R., and Zander, D.S. 2006. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.Arch. Pathol. Lab. Med. 130: 1503–1509PubMedGoogle Scholar
- Bhattacharya, B., Dilworth, H.P., Iacobuzio-Donahue, C., Ricci, F., Weber, K., Furlong, M.A., Fisher, C., and Montgomery, E. 2005. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.Am. J. Surg. Pathol. 29: 653–659PubMedCrossRefGoogle Scholar
- Guillou, L., Fletcher, J.A., Fletcher, C.D.M., and Mandahl, N. 2002. Extrapleural solitary fibrous tumor and heamangiopericytoma. In: Fletcher, C.D.M., Unni, K.K., Mertens, F., eds.Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC, pp. 86–88Google Scholar
- Miracco, C., de Santi, M.M., Pacenti, L., Schurfeld, K., Laurini, L., Pirtoli, L., Luzi, P., and Ninfo, V. 2001. Telomerase activity, Ki-67, cyclin D1 and A expression, and apoptosis in solitary fibrous tumors: additional features of a predictable course?Pathol. Res. Pract. 197: 475–481PubMedCrossRefGoogle Scholar
- Tejpar, S., Nollet, F., Li, C., Wunder, J.S., Michils, G., dal Cin, P., Van Cutsem, E., Bapat, B., van Roy, F., Cassiman, J.J., and Alman, B.A. 1999. Predominance of beta-catenin mutations and beta-catenin dysregu-lation in sporadic aggressive fibromatosis (desmoid tumor).Oncogene 18: 6615–6620PubMedCrossRefGoogle Scholar
- Travis, W.D., Churg, A., Aubry, M.C., Ordonez, N.G., Tazelaar, H., Pugatch, R., Manabe, T., and Miettinen, M. 2004. Mesenchymal tumours. In: Travis, W.D., Brambilla, E., Muller-Hermelink, H.K., Harris, C.C., eds.Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC, pp. 142–143Google Scholar
- Weiss, S.W., and Goldblum, J.R. 2001.Enzinger and Weiss's Soft Tissue Tumors. 4th ed. St. Louis, MO: CV MosbyGoogle Scholar